Injecting drug users' understanding of hepatitis C
Injecting drug users' understanding of hepatitis C
复制标题
DOI：
10.1016/j.addbeh.2008.07.005
复制
发表时间：
2008-12-01
影响因子：
4.4
通讯作者：
Dolan, Kate
中科院分区：
文献类型：
--
作者：
O'Brien, Susannah;Day, Carolyn;Dolan, Kate
这项横断面调查调查了注射吸毒者对丙型肝炎病毒的了解、病毒传播、临床标志物、症状和治疗的知识。注射吸毒者是通过澳大利亚新南威尔士州内城、郊区和地区的一系列场所进行招募和访谈的；招募了 149 名注射吸毒者。 74% 的参与者报告了最近的 HCV 检测，但许多注射吸毒者对各种检测的结果感到困惑，例如： 19% 的自称感染 HCV 的参与者认为自己不会感染他人或具有免疫力。注射吸毒者对丙型肝炎病毒的了解在传播风险（48％的人认为丙型肝炎病毒可能因重复使用自己的非共用针头而感染）、症状和临床标志物（42％的人认为丙型肝炎病毒抗体可以预防丙型肝炎病毒感染）和治疗方面存在显着差距。研究结果表明需要进一步制定和研究策略以提高注射吸毒者对丙型肝炎病毒的了解。 Crown 版权所有 (C) 2008 由 Elsevier Ltd 出版。保留所有权利。
This cross-sectional survey examined IDUs' understanding of HCV, their knowledge of virus transmission, clinical markers, symptoms and treatment. IDUs were recruited through and interviewed at a range of settings in inner-city, suburban and regional sites of New South Wales, Australia; 149 IDUs were recruited. Recent HCV testing was reported by 74% of participants, but a number of IDUs were confused about the results of the various tests, e.g. 19% of participants who stated they had HCV believed they could not infect others or were immune. Significant gaps in IDUs' knowledge of HCV were uncovered with respect to transmission risks (48% believed HCV could be contracted from re-using one's own, unshared needle), symptoms and clinical markers (42% believed HCV antibodies gave protection against HCV infection), and treatment. Findings warrant further development of, and research into, strategies to improve IDUs' understanding of HCV. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.